Lilly CFO Joshua Smiley Resigns Following Allegations of Inappropriate Personal Relationship -- Update
February 09 2021 - 8:15AM
Dow Jones News
By Dave Sebastian
Eli Lilly & Co. said Chief Financial Officer Joshua Smiley
has resigned after the company was made aware of allegations of an
inappropriate personal relationship between Mr. Smiley and an
employee.
Lilly on Tuesday said an independent investigation with an
external counsel found what it deemed consensual but inappropriate
communications between Mr. Smiley and certain employees and
"behavior that Lilly leadership concluded exhibited poor
judgment."
Mr. Smiley's alleged conduct wasn't related to financial
controls, financial statements or business matters, Lilly said. No
other employees resigned or were terminated in connection with Mr.
Smiley's conduct, a company spokeswoman said.
"Lilly holds all employees accountable to its core values and
strongly believes its executive officers carry an even higher
burden in ensuring those values are upheld," the drugmaker said.
"Mr. Smiley did not meet that standard."
The company said Mr. Smiley has agreed to forego all his $1
million 2020 cash bonus, about $3 million of his 2018-20
shareholder value award and all other current and future equity
incentive awards, totaling more than $20 million at target
value.
Succeeding Mr. Smiley is Anat Ashkenazi, who joined the company
in 2001 and most recently served as finance chief and controller of
Lilly Research Laboratories. Mr. Smiley will be available to assist
in the transition through July at a cash compensation of $9,000
every two weeks, the company said.
Mr. Smiley joined Lilly in 1995 and rose through the ranks to
become CFO in 2018.
The company in January reported a 41% rise in quarterly profit,
boosted by sales of its Covid-19 antibody treatment and higher
demand for its diabetes drugs.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
February 09, 2021 08:00 ET (13:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Apr 2023 to Apr 2024